Coca-Cola has a dividend yield that's more than double that of the S&P 500. Moody's has a large market share of the credit ratings segment.

DaVita HealthCare (DVA) reported earnings 30 days ago. What's next for the stock?

IMXI, SKWD and DVA made it to the Zacks Rank #1 (Strong Buy) value stocks list on March 14, 2024.

DENVER , March 8, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, and its group vice president of investor relations, Nic Eliason, will...

DaVita (DVA) stock soars as Novo Nordisk's study shows that although weight-loss drug reduces death risk for chronic kidney disease patients, demand for dialysis services will remain.

DaVita's (DVA) latest agreement is expected to serve a wider patient pool across Latin America.

DaVita HealthCare (DVA) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Here are the five stocks that qualify our screening criteria ??? RCL, DVA, F, FIS and ITRI.

Does DaVita HealthCare (DVA) have what it takes to be a top stock pick for momentum investors? Let's find out.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

The stock market has moved aggressively higher since the start of the year with the S&P 500 gaining 4.6% YTD and the Nasdaq 100 5.2%. While there is nothing inherently wrong with the market showing...

DaVita HealthCare (DVA) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

DaVita beat revenue and earnings estimates for its fourth quarter. The company has proven resilient in the wake of the COVID-19 pandemic.

Dialysis provider DaVita reported fourth-quarter financials above Wall Street's consensus.

DaVita's (DVA) robust segmental revenues drive its fourth-quarter performance.